The influence of type of feedback during tablet-based delivery of intensive treatment for childhood apraxia of speech.
Jacqueline McKechnie, Beena Ahmed, Ricardo Gutierrez-Osuna...
https://pubmed.ncbi.nlm.nih.gov/32693310/Actively Recruiting
Led by Murdoch Childrens Research Institute · Updated on 2026-09-11
20
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are evaluating whether speech therapy can improve speech accuracy in children aged 3 to 16 years who have childhood apraxia of speech CAS and rare genetic conditions. This study uses a single case experimental design to assess each child individually, focusing on how two specific motor speech therapy approaches affect speech accuracy and communication. The trial aims to understand the effects of these therapies on trained and untrained speech targets, speech intelligibility, and functional communication. Participants will receive one of two types of motor speech therapy Rapid Syllable Transition Treatment ReST or Dynamic Temporal and Tactile Cueing DTTC. Each child is assigned to one treatment based on age and speech ability. Therapy consists of 60-minute sessions three times a week over four weeks, totaling 12 sessions. Before treatment, participants undergo baseline speech assessments twice weekly for 1.5 to 2.5 weeks. After treatment, follow-up assessments occur at 1, 4, and 8 weeks to measure maintenance of progress. During the study, participants complete speech assessments repeatedly before, during, and after therapy to track changes in speech accuracy, intelligibility, and vocal control. Parents provide feedback on communication and quality of life. Speech sessions are monitored for quality, and adherence is supported by individualized speech targets. The total duration for each participant is about four months, including baseline, treatment, and follow-up phases, with ongoing evaluation of speech outcomes and therapy tolerability.
CONDITIONS
Speech Therapy for Children With Rare Genetic Conditions and Childhood Apraxia of Speech
M
Miya D St John, PhD
M
Maddy K Hill, MSpPath
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Murdoch Childrens Research Institute
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Twice weekly baseline speech assessments during this period
Duration - 4 weeks
Participants receive motor speech therapy using either Rapid Syllable Transition Treatment or Dynamic Temporal and Tactile Cueing. Therapy sessions last 45 to 60 minutes, three times per week, for four weeks.
Three therapy sessions per week (12 total sessions)
Duration - 8 weeks
Participants complete maintenance speech assessments at 1 week, 4 weeks, and 8 weeks after treatment to track speech progress.
Three follow-up assessments
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Jacqueline McKechnie, Beena Ahmed, Ricardo Gutierrez-Osuna...
https://pubmed.ncbi.nlm.nih.gov/32693310/Elizabeth Murray, Patricia McCabe, Kirrie J Ballard
https://pubmed.ncbi.nlm.nih.gov/25807891/Angela T Morgan, Elizabeth Murray, Frederique J Liégeois
https://pubmed.ncbi.nlm.nih.gov/29845607/Adam P Vogel, Lisa H Stoll, Andreas Oettinger...
https://pubmed.ncbi.nlm.nih.gov/30840144/Ilaria Scarcella, Letizia Michelazzo, Patricia McCabe
https://pubmed.ncbi.nlm.nih.gov/33830791/Donna C Thomas, Patricia McCabe, Kirrie J Ballard...
https://pubmed.ncbi.nlm.nih.gov/27161038/Agata Krasny-Pacini, Jonathan Evans
https://pubmed.ncbi.nlm.nih.gov/29253607/Elizabeth Murray, Patricia McCabe, Kirrie J Ballard
https://pubmed.ncbi.nlm.nih.gov/24686844/Maryane Gomez, Alison Purcell, Kathy Jakielski...
https://pubmed.ncbi.nlm.nih.gov/37855390/Maria I Grigos, Julie Case, Ying Lu...
https://pubmed.ncbi.nlm.nih.gov/38512002/Murdoch Childrens Research Institute
Lead Sponsor